Plant & Infrastructure

We have two facilities located in Karnataka, India. Our state-of-the-art infrastructure forms the backbone of our pharmaceutical API manufacturing capabilities.
We have a total installed reaction capacity more than150KL, consisting of SS and GL Reactors across our units, varying from 0.6 KL – 6 KL.The downstream equipment for drying, milling, sieving, micronization, and packaging is efficiently installed and operational.
We offer a range of manufacturing and testing solutions tailored to meet the needs of API manufacturers. Our core competency lies in our manufacturing capabilities, complemented by our proficiency in process development and analytical testing.

Upcoming GMP Block

New Production Block to Increase Capacity by 70KL

We are excited to announce that in the upcoming year, we will begin the construction of a new production block at our facility, set to be ready by June 2026. This strategic expansion will enhance our capacity to manufacture Active Pharmaceutical Ingredients (APIs) and meet the growing needs of our customers.

Key Features of the New Production Block

Increased Capacity: The new production block will add a total of 70 KL to our manufacturing capacity.
Comprehensive Utilities: The new block will include all necessary utilities for optimized production:
Facility Size: The new block will cover 4,500 sq. ft., with a total working area of 18,000 sq. ft., providing ample space for efficient manufacturing and streamlined processes.